Medicine on the Fringe: Stem Cell-Based Interventions in Advance of Evidence
Citations Over TimeTop 10% of 2009 papers
Abstract
Stem cell-based interventions (SCBIs) offer great promise; however, there is currently little internationally accepted, scientific evidence supporting the clinical use of SCBIs. The consensus within the scientific community is that a number of hurdles still need to be cleared. Despite this, SCBIs are currently being offered to patients. This article provides a content analysis of materials obtained from SCBI providers. We find content that strains credulity and almost no evidence of SCBIs being delivered in the context of clinical trials. We conclude that until scientific evidence is available, as a general rule, providers should only offer SCBIs in the context of controlled clinical trials. Clients should be aware that the risks and benefits of SCBIs are unknown, that their participation is unlikely to advance scientific knowledge, and they are likely to become ineligible to participate in future clinical trials of SCBIs. We recommend steps to promote patient education and enhance global oversight.
Related Papers
- → Hot vs. Cold Cases: Examining Time to Clearance for Homicides Using NIBRS Data(2007)51 cited
- → A survey of additive manufacturing trends for FDA-cleared medical devices(2023)20 cited
- The pulmonary clearance of bacteria by calves and mice.(1972)
- Studies on the components of Sokokju (old Korean cleared rice wine) and commercial Yakju (Korean cleared rice wine)(1981)
- → Various reports. The editorial floor, cleared of reports following reviews in The Gazette for October, 1965, has filled up again and must be re-cleared.(1966)